IP Library Granted Patent US 12,036,219
Granted Patent B2
US 12,036,219 · App. 14/775,465 · Granted Jul 16, 2024

Methods of treating infections in overweight and obese patients using antibiotics

Inventor: Erin M. Duffy (Deep River, CT)
Assignee: MELINTA SUBSIDIARY CORP.
A61K31/4709A61K9/0019A61K9/2013A61K9/2027A61K9/2054A61K31/133A61K47/183A61K47/26A61K47/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,036,219
App. No.
14/775,465
Granted
Jul 16, 2024
Kind
B2
Abstract

The present disclosure relates generally to methods of treating infections in overweight or obese patients using antibiotics. According to statistics compiled by National Health and Nutrition Examination Survey conducted by the National Center for Health Statistics (NCHS) of the U.S. Centers for Disease Control and Prevention (CDC), in 2009-2010, 35.7% of adults in the United States were found to be obese. Ogden, C.L. NCHS Data Brief 2012, 82, available at http://www.cdc.gov/nchs/data/databiefs/db82.pdf (last visited Mar. 2, 2013).

Claims (5)

1. A method of treating an Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in an overweight or obese patient in need thereof, the method comprising intravenously (IV) administering to the patient 300 mg of delafloxacin or a pharmaceutically acceptable salt, ester, or prodrug thereof, twice a day.

2. The method of claim 1 , wherein the overweight or obese patient has a body mass index greater than or equal to 25.

3. The method of claim 2 , wherein the overweight or obese patient has a body mass index greater than or equal to 30.

4. The method of claim 3 , wherein the overweight or obese patient has a body mass index greater than or equal to 35.

5. The method of claim 4 , wherein the overweight or obese patient has a body mass index greater than or equal to 40.

Assignments (8)
CORRECTIVE ASSIGNMENT TO CORRECT THE MAILING ADDRESS OF ASSIGNEE PREVIOUSLY RECORDED ON REEL 45324 FRAME 432. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jun 12, 2024
From: MELINTA THERAPEUTICS, INC.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 068463/0781 →
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 25, 2022
From: MELINTA SUBSIDIARY CORP.
To: SILICON VALLEY BANK
Reel/Frame 061314/0572 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 22, 2020
From: MELINTA SUBSIDIARY CORP.
To: SILICON VALLEY BANK
Reel/Frame 054836/0824 →
CHANGE OF NAME Recorded Mar 23, 2018
From: MELINTA THERAPEUTICS, INC.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 045324/0432 →
SECURITY INTEREST Recorded Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2018
From: SUCHARD SA LLC
To: MELINTA SUBSIDIARY CORP. (F/K/A MELINTA THERAPEUTICS, INC.)
Reel/Frame 044547/0939 →
SECURITY INTEREST Recorded Jun 28, 2017
From: MELINTA THERAPEUTICS, INC.
To: SUCHARD SA LLC
Reel/Frame 042854/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2015
From: DUFFY, ERIN M.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 037380/0903 →